News

SpiderTech launches kinesiology tape

BY Michael Johnsen

TORONTO — SpiderTech is one of the more recent companies to announce the launch of a kinesiology tape at retail. Kinesiology tape is trending, as evidenced by sales of one of the first tapes on the market — the KT Tape Pro, which generated growth of 258.5% toward a sales base of $5.8 million for the 52 weeks ended Aug. 10 across U.S. total multi-outlets, according to IRI.

(Click here to view the full category review.)

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Camber adds new execs

BY Michael Johnsen

PISCATAWAY, N.J. — Camber Consumer Care, which focuses on both consumer care and prescription-to-OTC switch products, recently introduced new executives to its staff.

John Segura has been named VP marketing and operations. He was most recently involved with the management and development of a private-label OTC division, including the integration of multiple manufacturing and packaging sites.

Vic Mazzacone has been named VP sales. Mazzacone has more than 25 years of sales leadership with such companies as GlaxoSmithKline and Novartis. Rich Matchett has been appointed as director of sales. He’s spent the last year-and-a-half in the private-label OTC market with Sun Pharma.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

External rubs bring formula of growth

BY Michael Johnsen

The resurgence of iconic pain relief brands Tylenol and Excedrin continue to contribute to the slight growth across internal analgesic tablets. It’s a $3.2 billion book of business across U.S. multi-outlets, according to IRI, that is up slightly by 0.8% for the 52 weeks ended Aug. 10. Specifically, McNeil Consumers’ Tylenol tablet business was up 50.9% to $242 million, while Novartis’ Excedrin business was up 91.1% to $61.8 million.

(Click here to view the full category review.)

But what’s trending across the analgesic category is external analgesic rubs, driven by pain relievers positioned as “natural,” like the homeopathic ingredient arnica, and TENS devices, of which a host are currently making their way to store shelves. Also, sales of kinesiology tape products are surging as more of those products come to market.

Two products containing emu oil are helping to bolster overall external analgesic rub sales growth of 8.1% to a dollar base of $495 million. Blue Emu realized 101.6% growth with $17.4 million in sales, and Australian Dream generated $15.2 million on 82.1% growth.

Boiron’s Arnicare comes in at $13.8 million on 43.9% growth. Soon to join Boiron on the shelf is Similasan with its portfolio of products under the Arnica Care banner, which includes a spray formula.

Also driving growth across external analgesic rubs is Hisamitsu’s Salonpas patch, which reached $55 million on 27.6% growth, making the product the No. 2 external analgesic behind Icy Hot. Salonpas sets itself apart with an extended pain relief claim of 12 hours vs. the 8 hours of relief many other products tout.

Omron entered the TENS therapy segment a couple years ago, but now there are a number of competitors entering the space. Chattem brought a TENS therapy device to market under its IcyHot banner featuring IcyHot spokesman Shaquille O’Neal. Carex Health Brands recently introduced AccuRelief Pain Relief Systems. And Drive Medical launched a TENS device called PainAway that features a remote control.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?